As of Apr 17
| +0.02 / +0.02%|
The 5 analysts offering 12-month price forecasts for Auspex Pharmaceuticals Inc have a median target of 101.00, with a high estimate of 105.00 and a low estimate of 101.00. The median estimate represents a +0.32% increase from the last price of 100.68.
The current consensus among 6 polled investment analysts is to Hold stock in Auspex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.